You are here: Industry Insights > cancer therapy

News List

Stevioside can increase efficiency of cancer therapy using magnetic nano particles: Scientists expresspharma
July 06, 2020
Coating nanoparticles with stevioside improved the cellular uptake of the nano-magnets in glioma C6 cancer cells and enhanced its retention time.
AUM Biosciences to develop Inflection’s cancer therapy pharmaceutical-technology
July 19, 2019
Biotechnology firm AUM Biosciences has entered a global licence agreement for Inflection Biosciences’ series of PIM/PI3K/mTOR inhibitor molecules.
Ascentage Pharma collaborates with Junshi Bioscience for cancer therapy biospectrumasia
April 10, 2019
Junshi Biosciences' self-developed toripalimab is the first anti-PD-1 monoclonal antibody marketed by a Chinese ^
J&J ends 2018 on a high, but coming year looks shaky pharmaphorum
January 24, 2019
Johnson & Johnson (J&J) has kicked off results season with a downbeat forecast for the year as competition to some of its top products starts to have an impact on revenues.
Flex-Salarius merger to focus on epigenetic cancer therapies pharmaceutical-technology
January 07, 2019
Flex Pharmaceuticals has announced it has entered into a definitive merger agreement with Salarius Pharmaceuticals for an undisclosed sum. The board of directors of both companies have approved the merger.....
Guardant to develop CDx and TMB liquid biopsy tests for AstraZeneca’s targeted cancer therapies fiercebiotech
December 26, 2018
AstraZeneca has tapped Guardant Health to develop blood-based companion diagnostics for its cancer treatments Tagrisso and Imfinzi.....
Janssen affiliate Cilag and Argenx sign deal for cancer therapy pharmaceutical-technology
December 05, 2018
Janssen Pharmaceutical affiliate Cilag International has signed a global collaboration and license agreement with Dutch biotechnology company Argenx for cusatuzumab (ARGX-110)....
T3 Pharmaceuticals Wins Prestigious Falling Walls Venture Award for Its Bacterial Cancer Therapy b3cnewswire
November 10, 2018
The Falling Walls Conference in Berlin, Germany, annually invites the world’s leading scientists to identify trends, opportunities and solutions for global challenges and discover international breakthrough research. Falling Walls Venture showcases the mo
AstraZeneca collaborates with Myriad Genetics for cancer therapy biospectrumasia
August 21, 2018
AstraZeneca is working in collaboration with the molecular diagnostics firm Myriad Genetics’ for its test myChoice HRD Plus to identify advanced ovarian cancer patients who might benefit from maintenance treatment using Lynparza (olaparib) and Avastin (be
Novartis Gets Creative in Pricing Next-Generation Cancer Therapy bloomberg
June 08, 2017
Novartis AG, set to beatKite Pharma Inc. to the finish line in one of the most promising new areas of cancer research, is examining how to price a revolutionary therapy patients will need to take just once.